Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
FDA Adds Heart Disease Risk, Diabetes Warning to Prostate Cancer Drugs October 21, 2010 Staff Writers Add Your CommentsFederal drug regulators are calling for new heart disease and diabetes warnings to be added to a class of prostate cancer drugs that includes Eligard, Lupron, Synarel, Trelstar, Vantas, Viadur, and Zoladex.ย On Wednesday, the FDA issued a drug safety alert, announcing that it was asking manufacturers to add the new warnings to all drugs belonging to a class known as gonadotropin-releasing hormone (GnRH) agonists. The warnings will alert patients and doctors that side effects of the drugs may include a small increased risk of diabetes and cardiovascular events, including heart attacks and strokes.The FDA launched a safety review of GnRH agonists in May. That review is ongoing.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONBefore the call for new label warnings, the FDA had already recommended that health care professionals be made aware of the potential risks and carefully weigh those risks before prescribing the drugs. The agency also recommended that patients prescribed a GnRH be monitored for diabetes and cardiovascular disease, and that cardiovascular risk factors, such as smoking and high blood pressure, be controlled while taking the medication. The FDA also warned patients not to stop treatment with GnRHโs unless instructed by their health care provider.GnRHโs suppress the production of testosterone, limiting the ability of prostate cancer to grow. The class of drugs includes Sanofi-Aventisโs Eligard, Abbott Laboratoriesโ Lupron, and Pfizerโs Synarel, among other brand names, as well as generic products. The drugs are also often used to treat women suffering from pain caused by endometriosis, and to treat anemia and breast cancer. It is also used in children to treat central precocious puberty. However, these uses have not been approved by FDA.The FDA estimates that there will be 217,730 new cases of prostate cancer among men this year, and that it will kill about 32,050 men, making it the second most common type of cancer among men in the U.S., behind skin cancer. Tags: Cancer, Diabetes, Eligard, Heart Attack, Heart Disease, Lupron, Pfizer, Prostate Cancer, Sanofi-Aventis, Stroke, Synarel, Trelstar, Vantas, Viadur, ZoladexMore Lawsuit Stories Abbott Spinal Cord Stimulator Lead Problems Caused Burning, Shocks, Lawsuit Alleges October 16, 2026 Olympus Medical Device Warning Letter Follows FDA Inspections of Six Manufacturing Facilities October 16, 2026 Dupixent Cancer Risks Lead Experts to Recommend Skin Biopsies Before Treatment October 16, 2026 2 Comments Petal November 11, 2010 Hello, My name is Petal J. from Trinidad. West Indies. I have had surgery in April 2008 for the removal of fibroid and my doctor insisted that I took the product Zoladex for six months. At the time I was 33 years old and I had gone thru menopause during the time I was taking the Zoladex. I had hot flashes, no period for six months etc. At present I am 35 years old and due to taking the product I have had rapid weight gain. I am 190 lbs fighting an obesity a problem I have never had before. All these things happened due to the fact that I have been injected for six months with the Zoladex product in 2008. Arthur October 23, 2010 I am a Bahamian. About a year ago I was advised that there was a tiny nodule on my prostate and my PSA level had risen to about 12. A biopsy performed in Orlando, Fla indicated Stage 2 cancer, which I was told was treatable. Prior to this, and starting radiation treatment, I was able to reduce the PSA count to 1.2 after using a suppository produced by a local urologist, Dr Joseph Evans, marketed under the brand name Navophos, although I was later informed that the active ingredient – afemale hormone- which I can’t recall at the moment, had been touted in a New York Times 1941 article as a breakthrough cure for cancer. At a local cancer forum, I was advised that “the cure” had been ordered withdrawn due to an association with heart attic susceptibility. On entering the local health system I was advised that I needed to switch to Zoladex in order to comply with eligibility requirements and also the fact that although ‘Navophos’ had been inquired about, it was not clear how it would impact the radiation treatment. After completing the radiation treatment, I was advised to have a new PSA test before a post-treatment assessment. However, at the time of the ‘post-treatment’ exam, I was advised that the result of the new PSA test had not been received and there would be no rectal exam as the effect of the radiation had probably left the area too sensitive for any ‘probing’, but I would be contacted about the results of the PSA test. After not being contacted after about three weeks I visited the local cancer radiation therapy centurion FridayOct 22 and was told the PSA test result had not yet been received and to check back the following week. Prior to this I visited my local GP and was told that my blood pressure, which had consistently been normal, was now somewhat lower. My occasional mild perspiring was attributed to ‘hot flashes’ as a result of the Zoladex. I am now awaiting the result of the PSA test. Another doctor has suggested that if it was him, he would have stayed on the Navophos even though it tended to leave one’s breasts in a somewhat ‘tender’ state. Apart from awaiting the results and any commentary about the PSA test, my next appointment with the radiation centre is in mid Jan 2011. Apart from the above, I still feel reasonably physically healthy. My urologist has advised that while the radiation therapy has an approximately 70% cure rate, additional hormonal therapy treatment increases this to about 90%. FacebookThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Abbott Spinal Cord Stimulator Lead Problems Caused Burning, Shocks, Lawsuit Alleges (Posted: 2 days ago)A Georgia womanโs spinal cord stimulator lawsuit alleges she suffered painful shocks and permanent injuries after an Abbott device’s leads migrated out of position.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITMaster Complaint for Spinal Cord Stimulator Lawsuits Against Boston Scientific to Be Filed (10/12/2026)Abbott and Nevro Spinal Cord Stimulator Lawsuits Centralized in New Federal MDLs (10/05/2026)Spinal Cord Stimulator Lawsuit Alleges Boston Scientific Device Failure Required Removal Surgery (09/29/2026) Dozens File Joint Nitrous Oxide Addiction Lawsuit Against Amazon, Third-Party Retailers (Posted: 3 days ago)A joint nitrous oxide addiction lawsuit accuses Amazon and numerous third-party retailers of knowingly selling nitrous oxide for illegal recreational use.MORE ABOUT: NITROUS OXIDE LAWSUITNitrous Oxide Injury Lawsuit Filed Over B12 Deficiency, Long-Term Side Effects (10/09/2026)Amazon, Online Nitrous Oxide Sellers Face Class Action Lawsuit Over Health and Safety Risks (09/04/2026)Nitrous Oxide Sales Restrictions Pass California Legislature Amid Growing Abuse Concerns (09/02/2026) Fourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (Posted: 4 days ago)A federal judge has scheduled a fourth Bard PowerPort bellwether trial to begin on December 1, while the third trial is slated to begin on October 13.MORE ABOUT: BARD POWERPORT LAWSUITJudge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026)Bard PowerPort Infection Lawsuit Set for Third Bellwether Trial to Begin Oct. 13 (09/14/2026)Jury Awards $40M Port Catheter Lawsuit Payout in Bard PowerPort Bellwether Trial (09/09/2026)
Olympus Medical Device Warning Letter Follows FDA Inspections of Six Manufacturing Facilities October 16, 2026
Abbott Spinal Cord Stimulator Lead Problems Caused Burning, Shocks, Lawsuit Alleges (Posted: 2 days ago)A Georgia womanโs spinal cord stimulator lawsuit alleges she suffered painful shocks and permanent injuries after an Abbott device’s leads migrated out of position.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITMaster Complaint for Spinal Cord Stimulator Lawsuits Against Boston Scientific to Be Filed (10/12/2026)Abbott and Nevro Spinal Cord Stimulator Lawsuits Centralized in New Federal MDLs (10/05/2026)Spinal Cord Stimulator Lawsuit Alleges Boston Scientific Device Failure Required Removal Surgery (09/29/2026)
Dozens File Joint Nitrous Oxide Addiction Lawsuit Against Amazon, Third-Party Retailers (Posted: 3 days ago)A joint nitrous oxide addiction lawsuit accuses Amazon and numerous third-party retailers of knowingly selling nitrous oxide for illegal recreational use.MORE ABOUT: NITROUS OXIDE LAWSUITNitrous Oxide Injury Lawsuit Filed Over B12 Deficiency, Long-Term Side Effects (10/09/2026)Amazon, Online Nitrous Oxide Sellers Face Class Action Lawsuit Over Health and Safety Risks (09/04/2026)Nitrous Oxide Sales Restrictions Pass California Legislature Amid Growing Abuse Concerns (09/02/2026)
Fourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (Posted: 4 days ago)A federal judge has scheduled a fourth Bard PowerPort bellwether trial to begin on December 1, while the third trial is slated to begin on October 13.MORE ABOUT: BARD POWERPORT LAWSUITJudge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026)Bard PowerPort Infection Lawsuit Set for Third Bellwether Trial to Begin Oct. 13 (09/14/2026)Jury Awards $40M Port Catheter Lawsuit Payout in Bard PowerPort Bellwether Trial (09/09/2026)